IGF2 and hepatocellular carcinoma: The commonly altered pathways in HCC include: IGF (in particular IGF2 and downstream mediators, as mTOR), p16/pRb (DNA repair pathway), p53/p21 (cell-cycle pathway), β-catenin, and trasforming growth factor (TGF)[6-18].